Results 18,961-18,980 of 34,663 for speaker:Seán Fleming
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: There is a different question. I want the officials from the Department of Public Expenditure and Reform to listen to this and take it back to the Department of Finance as well. Up to 2008, this scheme was exclusively a tax forgone scheme. I can fully understand why it was administered by Revenue. However, now the scheme is a grant scheme for expenditure, the vast majority of the payments...
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: The most recent figures relate to 2015. Do the Revenue Commissioners have estimates for 2016? What is the international comparison of research and development schemes for companies? How much of it is by way of tax forgone as opposed to grants?
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: Is that 60:40 split now-----
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: I ask Mr. Cody to get that this evening in order that we can see how that compares internationally.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: My next question relates to the first paragraph in the Comptroller and Auditor General's report which reads:The R&D tax credit can be claimed in addition to the standard 12.5% corporation tax deduction [because the scheme is worth 25%]. Therefore, the total tax benefit is 37.5%. Is that correct?
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: As Mr. Cody said, the emphasis is on the bigger foreign multinational companies. In 2013, the Department of Finance reviewed the important role it is playing. The scheme is also viewed as a very important element of Ireland’s corporation tax regime in terms of attracting foreign direct investment to Ireland. In light of Brexit and homegrown industries needing to increase their tax...
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: That is a bigger debate. We will not go there today. Essentially, does a company need to be paying tax at 12.5% to get the value of the corporation tax forgone?
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: Not assessable at that rate, but do they need to be-----
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: I think we are nearly there and I might ask the Comptroller and Auditor General to qualify. Everyone who is getting it at the 12.5% rate is paying some element of tax. If a company's credit is more than its tax liability, it might not only have no tax to pay but might also get a payable credit on top of that.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: The Comptroller and Auditor General is looking at me. Let me clarify. A company does not have to be paying. It could be a combination.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: It could cover all its profits.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: Paragraph 14.15 of the Comptroller and Auditor General's report reads, "However, analysis still needs to be carried out on a case-by-case basis to identify the specific R&D yield." That paragraph suggests that when the Revenue Commissioners go in as a result of an intervention, they might uncover VAT or some other issues.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: Therefore, not all that €46 million has to be research and development. Some of it could be VAT that the Revenue Commissioners picked up.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: That is going in.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: There is a reference to the effect that, "The yield amount quoted ... includes yield from other tax heads such as VAT, income tax etc." I am looking at paragraph 14.15.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: Revenue separated it out.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: Generally they were compliant. There were no other big issues.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriations Account
Chapter 13 - Revenue's Review of Medical Consultants' Tax Affairs
Chapter 14 - Research and Development Tax Credit
Chapter 16 - Deferral of Tobacco Stamp Liability (1 Jun 2017) Seán Fleming: That is all right. I just wanted to clear that up. We have finished our business. We agree to dispose of Chapters 13,14 and 16 of the 2015 Annual Report of the Comptroller and Auditor General. On behalf of the Committee on Public Accounts, I thank the witnesses from the Revenue Commissioners and the Comptroller and Auditor General. The meeting is adjourned.
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 20 - Garda Síochána - Internal Audit Report on Garda College, Templemore (Resumed) (31 May 2017) Seán Fleming: We are now in public session. We are joined by the Comptroller and Auditor General, Mr. Seamus McCarthy, who is a permanent witness at the committee. We will continue looking at the 2015 appropriation accounts, Vote 20, for An Garda Síochána, dealing specifically with the interim internal audit report on financial procedures in the Garda College. We met on this matter on 4 May...
- Public Accounts Committee: 2015 Annual Report of the Comptroller and Auditor General and Appropriation Accounts
Vote 20 - Garda Síochána - Internal Audit Report on Garda College, Templemore (Resumed) (31 May 2017) Seán Fleming: To clarify, there are no pairing arrangements in existence in the new politics of Dáil Éireann. From a practical point of view, a member can only pair with somebody who is voting in the opposite direction, and most of us, if we are not following the discussion-----